Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.
Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.
In 2018, the global Diabetic Macular Edema Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Diabetic Macular Edema Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Macular Edema Treatment development in United States, Europe and China.
The key players covered in this study
Market segment by Type, the product can be split into
Laser Photocoagulation Therapy
Market segment by Application, split into
Contract Research Organizations
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Diabetic Macular Edema Treatment status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Macular Edema Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Diabetic Macular Edema Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.